Results 201 to 210 of about 21,086 (303)

Continuity of care and risk of vision loss in patients with newly developed macular degeneration

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Neovascular age‐related macular degeneration (AMD) is a major cause of vision loss. Effective treatment requires sustained care, which may be influenced by continuity of care (COC). Understanding this association is crucial for improving patient outcomes.
In Hwan Cho   +5 more
wiley   +1 more source

OP0237 Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: combined evidence from 5 randomized controlled trials

open access: bronze, 2017
Christophe Baudouin   +8 more
openalex   +1 more source

Long‐term outcome of Coats' disease: Implications for the classification of foveal vascular pathologies

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To investigate the long‐term outcome in patients with Coats' disease regarding initial stages. Methods Within a retrospective, clinical, single centre study, patients with diagnosed Coats' disease treated from 1992 to 2019 (minimum follow‐up of 12 months) were investigated. A total of, 75 out of 123 patients met the inclusion criteria.
Claudia Brockmann   +5 more
wiley   +1 more source

Fellowships across Europe: Insights from the European Board of Ophthalmology Survey

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Analyse the results of a European Board of Ophthalmology (EBO) survey on post‐residency training (fellowship) opportunities across Europe, providing insights from ophthalmic educators on the current landscape. Methods A cross‐sectional study was conducted using an anonymous 31‐question online survey distributed to educators in all EBO ...
Rémi Yaïci   +22 more
wiley   +1 more source

Tumour progression shows decrease in PD‐L1 expression in matched metastases/primary uveal melanomas

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Immune checkpoint inhibitors (ICI) have revolutionised the treatment of several malignancies. However, the results of ICI therapy remain unsatisfactory in metastatic uveal melanoma (UM). We analysed the expression of PD1, PD‐L1, T‐cell and macrophage markers in a set of matched primary and metastatic UM in an attempt to better ...
Maria Chiara Gelmi   +5 more
wiley   +1 more source

Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]

open access: gold, 2018
Kelly K. Nichols   +8 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy